MDMA-Assisted Therapy for Stress Disorders in Healthcare Workers and First Responders
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorNautilus Sanctuary
About this trial
The purpose of this study is to assess the safety and efficacy of MDMA-Assisted Therapy on Frontline Health Care Workers and First Responders suffering from symptoms of Post-Traumatic Stress.
Eligibility criteria
Qualifiers
Were exposed to stressors related to their work in a health care setting or emergency response system
Are fluent in speaking and reading English.
Are able to swallow pills.
Agree to have study visits recorded, including Experimental Sessions, and non-drug therapy sessions.
Disqualifiers
Have previously participated in a clinical treatment trial using MDMA.
Have a past diagnosis of PTSD unrelated to their work in the healthcare or emergency response systems.
Have received Electroconvulsive Therapy (ECT) within 12 weeks of enrollment.
Have a history of or a current primary psychotic disorder or bipolar I disorder
Trial design
Treatments tested in this trial
- MDMA
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Nautilus Sanctuary
Lead sponsor
Nautilus Psychiatric Services, PLLC
Collaborator
Source ClinicalTrials.gov